Bumper Offer - Urjas oil Just @ Rs. 1
Ondero, a prescription drug, is manufactured in various forms such as Tablet. Diabetes are some of its major therapeutic uses.
The correct dosage of Ondero depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Ondero include Headache, Anxiety, Blurred vision. Besides the aforementioned side effects, there are other adverse effects of Ondero as well, which are listed below. Such side effects of Ondero normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Ondero is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Ondero has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Ondero related warnings section.
Individuals suffering from medical conditions like Diabetes Type 1, Diabetic Ketoacidosis, Pancreatitis must refrain from the use of Ondero since this can cause severe adverse effects. Other contraindications of Ondero have been discussed in the sections ahead.
Additionally, Ondero may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Ondero is considered safe while driving, and is addictive.
Ondero is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ondero is used -
Moderate
Common
Is the use of Ondero safe for pregnant women?
Ondero should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Ondero safe during breastfeeding?
Ondero should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Ondero on the Kidneys?
Ondero may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Ondero on the Liver?
Ondero can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Ondero on the Heart?
Ondero is rarely harmful for the heart.
Ondero should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ondero unless your doctor advises you to do so -
Is this Ondero habit forming or addictive?
Ondero is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Ondero since it will not make you feel sleepy.
Is it safe?
Ondero is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Ondero cannot treat any kind of mental disorder.
Interaction between Food and Ondero
Due to the absence of research, it is difficult to say how Ondero and food will interact.
Interaction between Alcohol and Ondero
Drinking alcohol while taking Ondero may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 776
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tradjenta™ (linagliptin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 776
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tradjenta™ (linagliptin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 776
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tradjenta™ (linagliptin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 776
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tradjenta™ (linagliptin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 776
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tradjenta™ (linagliptin)